(Q36410040)

English

Direct comparison of an inactivated subvirion influenza A virus subtype H5N1 vaccine administered by the intradermal and intramuscular routes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Direct comparison of an inactivated subvirion influenza A virus subtype H5N1 vaccine administered by the intradermal and intramuscular routes (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

influenza A virus

object named as

influenza A virus

1 reference

based on heuristic

inferred from title

2

object named as

Robert L Atmar

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

6

object named as

Wendy A Keitel

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

5

object named as

Heather Hill

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

author name string

Shital M Patel

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Hana M El Sahly

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Kuo Guo

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

language of work or name

0 references

publication date

13 August 2012

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

206

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

7

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1069-1077

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

30 September 2017

Influenza vaccines for the future

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

30 September 2017

Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

30 September 2017

Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

30 September 2017

A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

30 September 2017

Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

30 September 2017

Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

30 September 2017

Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

30 September 2017

Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

30 September 2017

Intradermal hepatitis B vaccination: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

30 September 2017

Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

30 September 2017

Pandemic H5N1 influenza vaccine development: an update.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

30 September 2017

Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

30 September 2017

Preparing for a possible pandemic: influenza A/H5N1 vaccine development.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

30 September 2017

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

30 September 2017

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

30 September 2017

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

30 September 2017

Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

28 June 2018

Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

21 September 2018

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

21 September 2018

Immunization with Asian-strain influenza vaccine: equivalence of the subcutaneous and intradermal routes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3501693

21 September 2018

Dose sparing with intradermal injection of influenza vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/22891287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunologic reactions following the intradermal inoculation of influenza A and B vaccine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22891287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the intradermal and subcutaneous routes of influenza vaccination with A/New Jersey/76 (swine flu) and A/Victoria/75: report of a study and review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/22891287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/22891287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Pre-exposure intradermal rabies vaccination using Japanese rabies vaccine following WHO recommended schedule]

1 reference

https://pubmed.ncbi.nlm.nih.gov/22891287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influenza vaccination; comparison of intracutaneous and subcutaneous methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/22891287

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/INFDIS/JIS402

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36410040&oldid=1979198428"